ATE293961T1 - Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie - Google Patents

Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie

Info

Publication number
ATE293961T1
ATE293961T1 AT02003106T AT02003106T ATE293961T1 AT E293961 T1 ATE293961 T1 AT E293961T1 AT 02003106 T AT02003106 T AT 02003106T AT 02003106 T AT02003106 T AT 02003106T AT E293961 T1 ATE293961 T1 AT E293961T1
Authority
AT
Austria
Prior art keywords
hydantoin
hypalbuminaemia
derivatives against
alkyl
independently
Prior art date
Application number
AT02003106T
Other languages
English (en)
Inventor
Kazuharu Ienaga
Ryoji Nishibata
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE293961T1 publication Critical patent/ATE293961T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02003106T 2001-02-13 2002-02-13 Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie ATE293961T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001035262A JP4711523B2 (ja) 2001-02-13 2001-02-13 低アルブミン血症改善剤

Publications (1)

Publication Number Publication Date
ATE293961T1 true ATE293961T1 (de) 2005-05-15

Family

ID=18898735

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02003106T ATE293961T1 (de) 2001-02-13 2002-02-13 Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie

Country Status (11)

Country Link
US (1) US6451831B1 (de)
EP (1) EP1243261B1 (de)
JP (1) JP4711523B2 (de)
KR (1) KR100842240B1 (de)
CN (1) CN1197572C (de)
AT (1) ATE293961T1 (de)
AU (1) AU777602B2 (de)
CA (1) CA2371517C (de)
DE (1) DE60203844T2 (de)
ES (1) ES2237625T3 (de)
TW (1) TWI236907B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4711523B2 (ja) * 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
TWI353979B (en) 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20060241162A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (R)-hydantoin derivative
US20060241163A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (S)-hydantoin derivative
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
CN103476923B (zh) 2010-10-14 2015-04-29 日本脏器制药株式会社 软骨细胞中的胶原蛋白和蛋白聚糖合成的促进方法
JP7146194B2 (ja) 2017-06-13 2022-10-04 国立研究開発法人国立がん研究センター 発がん抑制剤
KR102643231B1 (ko) 2021-07-02 2024-03-05 주식회사 경보제약 ５­히드록시­１­메틸이미다졸리딘­２，４­디온 화합물을 유효성분으로 포함하는 동물용 약학적 조성물

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4099007A (en) 1969-04-02 1978-07-04 Hoechst Aktiengesellschaft N,n-substituted 2,4,5-triketoimidazolidines and a process for their preparation
US3818031A (en) 1971-03-26 1974-06-18 Ciba Geigy Corp Imidazolidinetrionecarboxylic acid derivatives
CH563711A5 (en) 1972-03-03 1975-07-15 Ciba Geigy Ag Agents for regulating plant metabolism - contg. imidazolidine-2,4,5-trione-3-carboxylic acid derivs.
IL39042A (en) 1971-03-26 1976-04-30 Ciba Geigy Ag 2,4,5-trioxoimidazolidine-1-carboxylic acid derivatives,their preparation and their use for the control of plant metabolism
DE2612926A1 (de) 1976-03-26 1977-10-06 Boehringer Mannheim Gmbh Neue acyl-derivate der 6-(alpha- amino-phenylacetamido)-penicillansaeure
JPS554305A (en) 1978-06-13 1980-01-12 Nippon Zoki Pharmaceut Co Ltd Remedy for disease caused by stress and its preparation
AU578068B2 (en) 1984-03-08 1988-10-13 Nippon Zoki Pharmaceutical Co., Ltd. Hydantoin derivatives and pharmaceutical compositions containing them
JPH0686436B2 (ja) 1984-11-15 1994-11-02 日本臓器製薬株式会社 新規ヒダントイン誘導体及び該化合物を含有する医薬組成物
BE899531A (fr) 1984-04-27 1984-08-16 Wallone Region Derives sulfures de l'hydantoine et compositions pharmaceutiques les contenant.
US4658830A (en) 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
CA1265052A (en) 1984-08-08 1990-01-30 Stanley J. Sarnoff Absorption enhancing agents
US5078680A (en) 1984-08-08 1992-01-07 Survival Technology, Inc. Automatic injector for emergency treatment
US4661469A (en) 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
US4832682A (en) 1984-08-08 1989-05-23 Survival Technology, Inc. Injection method and apparatus with electrical blood absorbing stimulation
US4656034A (en) 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents
US5340829A (en) 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
JPH0764729B2 (ja) * 1985-02-06 1995-07-12 日本臓器製薬株式会社 イミダゾリジントリオン誘導体を含有する医薬組成物
EP0194226B1 (de) 1985-02-06 1990-02-07 Nippon Zoki Pharmaceutical Co. Ltd. Ein Imidazolidintrion-Derivat oder ein seiner pharmazeutisch akzeptierbaren Salze enthaltende pharmazeutische Zusammenstellung
JPS62224259A (ja) * 1986-03-26 1987-10-02 Sanwa Kagaku Kenkyusho Co Ltd 栄養食
JP2567593B2 (ja) 1986-12-29 1996-12-25 日本臓器製薬株式会社 イミダゾリジントリオン誘導体及び該化合物を有効成分として含有するアレルギ−性疾患治療剤
JPS6456614A (en) 1987-08-27 1989-03-03 Ono Pharmaceutical Co Maillard reaction inhibitor
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
JP2673381B2 (ja) * 1990-02-23 1997-11-05 持田製薬 株式会社 糖尿病前症治療剤および／または脂質低下剤
JPH01156965A (ja) 1987-09-29 1989-06-20 Taiho Yakuhin Kogyo Kk チオヒダントイン化合物
JPH0219363A (ja) 1988-07-06 1990-01-23 Fujisawa Pharmaceut Co Ltd イミダゾリジン誘導体
JP2544183B2 (ja) 1988-07-29 1996-10-16 日本臓器製薬株式会社 新規パラバン酸誘導体及び該化合物を有効成分として含有する医薬組成物
JPH0262891A (ja) * 1988-08-30 1990-03-02 Takeshi Takahashi タンパク尿症改善剤
JP2817219B2 (ja) 1988-09-08 1998-10-30 武田薬品工業株式会社 カルバジン酸誘導体、その製造法及び製剤
JPH02225485A (ja) 1989-02-27 1990-09-07 Taiho Yakuhin Kogyo Kk チエノピリミジン―３―酢酸誘導体
CA2011899A1 (en) 1989-03-13 1990-09-13 Masaaki Toda Benzopyran derivatives
JP2678499B2 (ja) * 1989-08-09 1997-11-17 日本臓器製薬 株式会社 尿毒症毒素低下剤
JP2936171B2 (ja) * 1989-09-01 1999-08-23 東ソー株式会社 血清アルブミンの製造方法
JPH0667827A (ja) 1992-08-18 1994-03-11 Nec Software Ltd データ表示制御装置
JP3267698B2 (ja) 1992-10-27 2002-03-18 株式会社三和化学研究所 ヒダントイン誘導体及びその塩並びにこれらを有効成分とするメイラード反応阻害剤
PT638075E (pt) 1993-02-26 2002-06-28 Otsuka Pharma Co Ltd Inibidor da reaccao de maillard
JPH06305964A (ja) 1993-02-26 1994-11-01 Otsuka Pharmaceut Co Ltd メイラード反応阻害剤
EP0640594A1 (de) * 1993-08-23 1995-03-01 Fujirebio Inc. Hydantoinderivat als Metalloproteaseinhibitor
EP0721944B1 (de) 1994-07-29 2001-01-17 Suntory Limited Imidazolidin-derivate und ihre verwendung
JPH08157473A (ja) 1994-10-06 1996-06-18 Nissan Chem Ind Ltd ピラゾール系チアゾリジン類
US5681843A (en) 1994-12-20 1997-10-28 Nippon Zoki Pharmaceutical Co., Ltd. Parabanic acid derivatives
US5912261A (en) 1994-12-20 1999-06-15 Nippon Zoki Pharmaceutical Co., Ltd. Carboxyalkyl heterocyclic derivatives
US5840713A (en) * 1995-04-03 1998-11-24 Weisz; Paul B. Therapy for tissue membrane insufficiency
JP3204874B2 (ja) 1995-06-09 2001-09-04 株式会社クボタ キャビンのドア装置
JP3836203B2 (ja) * 1995-12-20 2006-10-25 日本臓器製薬株式会社 活性酸素・フリーラジカル消去剤
US6197806B1 (en) * 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
JPH10182460A (ja) 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd ３−デオキシグルコソン生成阻害剤
JPH10251161A (ja) * 1997-03-11 1998-09-22 Green Cross Corp:The 浮腫治療効果増強剤
WO1999034813A1 (en) * 1998-01-05 1999-07-15 Johns Hopkins University Supplement for dialysis patients
AR018818A1 (es) * 1998-04-03 2001-12-12 Yamano Masaki Una composicion farmaceutica para la terapia de un edema.
AU754989B2 (en) * 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
FR2796945B1 (fr) * 1999-07-30 2002-06-28 Sod Conseils Rech Applic Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
US6462063B1 (en) * 2000-02-04 2002-10-08 Fibrogen, Inc. C-proteinase inhibitors
JP4711523B2 (ja) * 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤

Also Published As

Publication number Publication date
US6451831B1 (en) 2002-09-17
AU1554302A (en) 2002-08-15
CA2371517C (en) 2010-12-21
AU777602B2 (en) 2004-10-21
KR20020066959A (ko) 2002-08-21
CN1371687A (zh) 2002-10-02
JP2002241283A (ja) 2002-08-28
EP1243261A1 (de) 2002-09-25
ES2237625T3 (es) 2005-08-01
CN1197572C (zh) 2005-04-20
KR100842240B1 (ko) 2008-06-30
DE60203844T2 (de) 2006-01-19
DE60203844D1 (de) 2005-06-02
EP1243261B1 (de) 2005-04-27
TWI236907B (en) 2005-08-01
JP4711523B2 (ja) 2011-06-29
CA2371517A1 (en) 2002-08-13
US20020147228A1 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
NL300927I1 (nl) tivozanib of een zout of hydraat ervan, in het bijzonder het hydrochloride-monohydraat
EP1369418A4 (de) Chinazolinderivate
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
NO20051263L (no) Ny anvendelse av benzotiazolderivater
NO20055655D0 (no) Anvendelse av azetidinkarboksamidderivater i terapi
GB0111523D0 (en) Chemical compounds
PT1159279E (pt) 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
NO20052698L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
PT992509E (pt) Novos derivados macrolidos
MXPA04006041A (es) Antivirales de piridoquinoxalina.
ATE293961T1 (de) Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie
DE60127535D1 (de) Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation
TW200505446A (en) Inhibitor of cox
DE60204611D1 (de) Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren
DE69617226D1 (de) Piperidinderivate.
ATE322479T1 (de) Benzamidinderivate
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
ATE319452T1 (de) Arzneimittel gegen essstörungen
ATE469884T1 (de) Indolinverbindung und deren medizinische verwendung
DE69410159D1 (de) Neue Verbindung, Leustroducsin H, ihre Herstellung und therapeutische Verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1243261

Country of ref document: EP

REN Ceased due to non-payment of the annual fee